With the global biotechnology market expected, by one estimate, to almost double from its $448 billion level last year to $833 billion by 2027, today’s article highlights two biotech exchange-traded funds for those who play the space to monitor, as both could be poised to break out to new all-time highs. For a look at these two biotech ETFs – and possible upcoming trading plays for both – CLICK HERE.